Vistagen Therapeutics, Inc. — DEF 14A Filings
14 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by Vistagen Therapeutics, Inc. (VTGN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Vistagen Therapeutics, Inc. has filed 14 DEF 14A documents with the SEC since 2007. To view all SEC filings by Vistagen Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10QSB
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-A12G
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRER14A
RW
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SB-2
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SC 14F1/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001411685-25-000052 | Jul 28, 2025 | Sep 9, 2025 |
| DEF 14A | DEF 14A | 0001411685-24-000028 | Jul 17, 2024 | Aug 26, 2024 |
| DEF 14A | FORM DEF 14A | 0001437749-24-012129 | Apr 16, 2024 | May 29, 2024 |
| DEF 14A | FORM DEF 14A | 0001437749-23-021049 | Jul 28, 2023 | Sep 25, 2023 |
| DEF 14A | FORM DEF 14A | 0001851734-22-000517 | Aug 31, 2022 | Oct 14, 2022 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001654954-21-008334 | Jul 29, 2021 | Sep 17, 2021 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001654954-21-000472 | Jan 14, 2021 | — |
| DEF 14A | DEF 14A | 0001654954-20-008042 | Jul 27, 2020 | Sep 17, 2020 |
| DEF 14A | DEF 14A | 0001654954-19-008434 | Jul 23, 2019 | Jul 26, 2019 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001654954-18-008147 | Jul 27, 2018 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001654954-17-006956 | Aug 4, 2017 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001415889-16-006705 | Aug 8, 2016 | Sep 26, 2016 |
| DEF 14A | DEF 14A | 0001415889-15-002609 | Aug 11, 2015 | — |
| DEF 14A | — | 0001415889-11-001094 | Oct 12, 2011 | Oct 11, 2011 |